A new study from Public Health England found that the COVID-19 variant first discovered in the United Kingdom in December could be more resistant to vaccines due to a new mutation, The Hill reported Tuesday.
While existing vaccines are effective against the B.1.1.7 strain, a new mutation, known as E484K, has appeared and proven to cause vaccine-resistance, The Hill reported. (RELATED: First Known Case Of Brazilian Coronavirus Variant Strain Detected In US).
Rocky Mountain Regional VA Medical Center investigational pharmacy technician Sara Berech is reflected in the glass of a fume hood as she prepares a dose of the Johnson & Johnson COVID-19 vaccine for a clinical trial on December 15, 2020 in Aurora, Colorado. (Photo by Michael Ciaglo/Getty Images)
Johnson & Johnson and Novavax provided data showing that their vaccines are not as effective against strains with the new mutation, The Hill reported.